The subscription period for OrganoClick AB's ("OrganoClick AB" or "the Company") new share issue with preferential rights for existing shareholders amounting to approximately 20.3 MSEK, before issuance costs ("Preferential Issue"), which was decided by the board on July 17, 2025 and approved by the extraordinary general meeting on August 5, 2025, ended on August 22, 2025. A total of 9,142,328 shares were subscribed, corresponding to approximately 79.2 percent of the Rights Issue, with the support of subscription rights. In addition, 961,801 shares, corresponding to approximately 8.3 percent of the Rights Issue, have been subscribed without the support of subscription rights. 1,439,161 shares, corresponding to approximately 12.4 percent of the Rights Issue, have thus been subscribed under the fulfillment of guarantee commitments made by the issue guarantors, consisting of the Company's three largest shareholder groups. No guarantee fee is paid as a result of the fulfillment of the issue guarantees. The Rights Issue was thus subscribed to 100 percent, and through the Rights Issue, the Company will be provided with approximately 20.3 million SEK before issue costs.
THIS PRESS RELEASE MAY NOT BE DISTRIBUTED, PUBLISHED, OR ANNOUNCED, DIRECTLY OR INDIRECTLY, WITHIN OR TO AUSTRALIA, BELARUS, CANADA, HONG KONG, JAPAN, NEW ZEALAND, RUSSIA, SINGAPORE, SOUTH AFRICA, SOUTH KOREA, SWITZERLAND, THE USA OR ANY OTHER JURISDICTION WHERE SUCH DISTRIBUTION, PUBLICATION, OR ANNOUNCEMENT WOULD BE IN VIOLATION OF APPLICABLE REGULATIONS OR REQUIRE FURTHER REGISTRATION OR OTHER ACTIONS. PLEASE SEE THE SECTION 'IMPORTANT INFORMATION' AT THE END OF THIS PRESS RELEASE.
Outcome of the Rights Issue
The subscription period for the Rights Issue ended on August 22, 2025. A total of 9,142,328 shares were subscribed for in the Rights Issue, corresponding to approximately 16,090,497.28 SEK, with about 79.2 percent of the Rights Issue supported by subscription rights. In addition, subscription applications have been received for 961,801 shares, corresponding to approximately 8.3 percent, without the support of subscription rights. Thus, the total subscription of the Rights Issue, both with and without the support of subscription rights, amounted to approximately 87.5 percent. Since the Rights Issue is fully guaranteed at 100 percent through guarantees, the guarantors have subscribed for the remaining 1,439,161 shares (without any guarantee fee for the Company), corresponding to approximately 10 percent of the Rights Issue. OrganoClick AB will receive approximately 20.3 million SEK before deducting emission costs, which are estimated to be around 0.4 million SEK.
Increase in the number of shares and share capital through the Rights Issue
Through the Rights Issue, the number of shares in the Company will increase by 11,543,290 from 98,459,726 to 110,003,016 and the share capital will increase by 115,432.903642 SEK from 984,597.291068 SEK to 1,100,030.19471 SEK, corresponding to a dilution effect of approximately 10 percent of the share capital and the number of votes.
Notification of allocation in the Rights Issue
Notification of the allocation of shares subscribed for without support of subscription rights has been sent to those who have been allocated shares via settlement note on August 25, 2025. Shareholders who have their shares registered through a nominee will receive notification of allocation according to the respective nominee's procedures.
Trading with BTA
Trading with paid subscribed shares ("BTA") will take place on Nasdaq First North Growth Market until the Rights Issue has been registered with the Swedish Companies Registration Office. The last day for trading in BTA is expected to occur on September 2, 2025.
Advisor
The law firm Delphi is the legal advisor to OrganoClick AB in connection with the transaction. Eminova Fondkommission AB acts as the issuing institute in the transaction.
For more information, please contact:
Mårten Hellberg, CEO OrganoClick AB
08-684 001 10, marten.hellberg@organoclick.com
About OrganoClick
OrganoClick is a Swedish green chemical company, founded in 2006 replacing hidden plastic and harmful chemicals in fiber-based materials with green chemical solutions based on fossil-free raw materials. Based on the company's patented "OrganoClick" technologies, which are inspired by nature's chemistry, OrganoClick develops, produces and markets a range of products with the aim of enabling a green transition. For example, the biobased binder OC-BioBinder for the nonwoven and paper industry, the biodegradable textile impregnation OrganoTex® for consumers and the textile industry, the biocidal-free wood protection technology OrganoWood® for wood treatment companies and the construction industry, as well as eco-labelled maintenance products for home owners under the BIOkleen brand. OrganoClick was founded as a spin-off from Stockholm University and the Swedish Agricultural University and has received several awards for its green innovations, including being named a "Climate Solver" by the World Wide Fund for Nature - WWF. The company is listed on the Nasdaq First North Growth Market and has its headquarters, production and R&D in Täby, north of Stockholm. OrganoClick's Certified Adviser on the Nasdaq First North Growth Market is Mangold Fondkommission AB, tel: +46 (0)8 503 01 551, email: ca@mangold.se.
Important Information
The information in this press release does not constitute an offer to acquire, subscribe for, or otherwise trade in shares, subscription rights, or other securities in OrganoClick. The information in this message is intended solely as a basis for information and does not claim to be complete or comprehensive. No person should rely on the information in this press release for any purpose or on its accuracy, fairness, or completeness.
This press release does not constitute a prospectus under the European Parliament and Council Regulation (EU) 2017/1129 of June 14, 2017, on prospectuses to be published when securities are offered to the public or traded on a regulated market, and repealing Directive 2003/71/EC (together with related delegated regulations and implementing regulations, the "Prospectus Regulation").
This press release or the information in this press release may not, in whole or in part, be published, distributed, or disseminated, directly or indirectly, in or to Australia, Belarus, Canada, Hong Kong, Japan, New Zealand, Russia, Singapore, South Africa, South Korea, Switzerland, or the USA or any other jurisdiction where such action is subject to legal restrictions in whole or in part or where such action would require additional prospectuses, registrations, or other actions beyond what is required under Swedish law. The information in this press release may also not be forwarded, reproduced, or published in a manner that contravenes such restrictions or would entail such requirements. Actions in violation of this instruction may constitute a breach of applicable securities legislation.
No subscription rights, paid subscribed shares (BTA), or new shares have been registered, nor will they be registered, under the United States Securities Act of 1933, as amended (the "Securities Act") or the securities laws of any state or other jurisdiction in the U.S., and no subscription rights, paid subscribed shares (BTA), or new shares may be offered, subscribed, exercised, pledged, granted, sold, resold, delivered, or otherwise transferred, directly or indirectly, in or to the U.S., except pursuant to an applicable exemption from, or in a transaction not subject to, the registration requirements of the Securities Act. Furthermore, the securities mentioned in this press release have not been registered and will not be registered under applicable securities legislation in Australia, Belarus, Canada, Hong Kong, Japan, New Zealand, Russia, Singapore, South Africa, South Korea, or Switzerland and may, with certain exceptions, not be offered or sold to or within, or on behalf of a person who is registered, resides or is located in, these countries or any other jurisdiction where the disclosure, distribution or publication would be illegal or require registration or any other action. The company has not made any offer to acquire the securities mentioned in this press release to the public in any country other than Sweden.
In the EEA member states, other than Sweden, (each such EEA member state referred to as a "Relevant State"), this press release and the information contained herein is only intended for and directed at qualified investors as defined in the Prospectus Regulation. The securities mentioned in this press release are not intended to be offered to the public in any Relevant State and are only available to qualified investors except in accordance with an exemption under the Prospectus Regulation. Persons in a Relevant State who are not qualified investors should not take any action based on this press release and should not rely on it.
In the United Kingdom, this press release and other material concerning the securities mentioned herein are distributed and directed only to, and an investment or investment activity related to this document is only available to and may only be utilized by, 'qualified investors' (in the meaning given in the UK version of the EU Prospectus Regulation (2017/1129/EU) incorporated into UK law by the European Union (Withdrawal) Act 2018) who (i) have professional experience in investment matters falling within Article 19(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (as amended, 'the Order'), (ii) are persons falling within Article 49.2 a-d ('high net worth companies, unincorporated associations etc.') in the Order, (iii) are located outside the United Kingdom, or (iv) are persons to whom an invitation or encouragement to participate in investment activities (in the meaning given in Section 21 in the Financial Services and Markets Act 2000) in connection with the issuance or sale of securities in any other way that can be legally communicated or allowed to be communicated (all these persons are collectively referred to as "relevant persons"). This press release is addressed only to relevant persons and should not be used by persons who are not relevant persons. Any investment or investment activity to which this announcement refers is only available to relevant persons and will only be conducted with relevant persons.
